Catherine M Broome

14PUBLICATIONS
40CO-AUTHORS
Infant and child healthAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 05, 2026
Classical Complement Pathway Inhibition in a Pediatric Patient With Refractory Immune Thrombocytopenia.

|Aug 08, 2026
Treatment of Cold Agglutinin Syndrome Secondary to Chronic Lymphocytic Leukemia With Sutimlimab and Obinutuzumab-Venetoclax.

|Apr 16, 2026
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.

|Apr 06, 2026
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial.

Nichola Cooper, Catherine M Broome, Yoshitaka Miyakawa

|Feb 22, 2024
COVID-19 vaccine safety and immunogenicity in patients with cold agglutinin disease receiving concomitant sutimlimab.

Bruno Fattizzo, Alexander Röth, Catherine M Broome

|May 29, 2023
Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease.

Alexander Röth, Wilma Barcellini, Shirley D'Sa

Pageof 3

Frequent Collaborators

4 joint publications

Alexander Röth

3 joint publications

Wilma Barcellini

2 joint publications

David J Kuter

2 joint publications

Marek Wardȩcki